ID: ALA4170612

Max Phase: Preclinical

Molecular Formula: C27H40N2O2S

Molecular Weight: 456.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]2(O)CNC(=S)Nc1ccccc1

Standard InChI:  InChI=1S/C27H40N2O2S/c1-25-13-10-20(30)16-18(25)8-9-21-22(25)11-14-26(2)23(21)12-15-27(26,31)17-28-24(32)29-19-6-4-3-5-7-19/h3-7,18,20-23,30-31H,8-17H2,1-2H3,(H2,28,29,32)/t18-,20-,21+,22-,23-,25-,26-,27+/m0/s1

Standard InChI Key:  IEAFZCHPFVSGFO-ACEZCWTCSA-N

Associated Targets(Human)

HBL-100 746 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SW1573 1008 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T47D 39041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

WiDr 1835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 456.70Molecular Weight (Monoisotopic): 456.2810AlogP: 5.11#Rotatable Bonds: 3
Polar Surface Area: 64.52Molecular Species: NEUTRALHBA: 3HBD: 4
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.34CX Basic pKa: CX LogP: 4.95CX LogD: 4.95
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.48Np Likeness Score: 0.96

References

1. Romero-Hernández LL, Merino-Montiel P, Meza-Reyes S, Vega-Baez JL, López Ó, Padrón JM, Montiel-Smith S..  (2018)  Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs.,  143  [PMID:29172080] [10.1016/j.ejmech.2017.10.063]

Source